Increasing The Odds Against Pancreatic Cancer

Many people believe there are no long-term survivors from pancreatic cancer — but thankfully, that’s not true. Ask Richard Luze, associate vice chancellor for development programs at Washington University, who is cancer-free six years after his diagnosis. He received aggressive therapy from Washington University specialist at the Siteman Cancer cneter and Barnes-Jewish Hospital. “I was treated at one of the top places in the Untied States for pancreatic cancer, and some of the best doctors in the country were part of my medical team,” Luze says. “They were outstanding, and the care I received was wonderful.”

Since pancreatic cancer is so often deadly, it needs to be managed by experts who specialize in treating the disease. Siteman has one of the highest-volume pancreatic cancer programs in the United States. The three Washington Unviersity surgeons in the program perform close to 200 pancreatic operations each year.

Pioneering New Procedures for Better Survival

Among the operations are some 125 Whipple procedures, a complex operation that includes removing the head of the pancreas — if the cancer has arisen in that area — along with the gallbladder, the common bile duct, most of the duodenum and part of the stomach. Washington Unviersity surgeon Steven Strasberg, MD, has played an instrumental role in refining the procedure in recent years. He and his colleagues pioneered a modification to the technique that involves sewing the pancreatic duct to the bowel during surgery, which drastically reduces the risk of life-threatening leakages from 15 percent to less than 2 percent.

Surgical mortality and morbidity rates from the Whipple procedure are extremely low at Stieman, where surgeons have lengthy experience in performing it. Mortality rates are less than two percent. For pancreatic cancers that arise in the body and tail of the pancreas, these Washington University surgeons have also developed a highly effective removal procedure called RAMPS (radical antegrade modular pancreatosplenectomy) with encouraging survival rates.

Making Progress Through Research

We feel strongly that every patient with pancreatic cancer should be in a clinical trail to test novel methods of diagnosis and treatment,” says surgeon David Linehan, MD. “Without this kind of study, we can’t make much progress against this disease.

Linehan and other members of Siteman’s pancreatic cancer team are also scientists who engage in basic and clinical research that can translate into new treatments. In a newly published study, they showed that an aggressive and creative combination of treatment methods –the Whipple procedure, chemotherapy, immunotherapy and radiation therapy — resulted in an extraordinary three-year overall survival rate of 41 percent. Richard Luze was the third patient entered in this study, soon after it began.

Other studies also show promise for the future. One is investigating genetic biomarkers that can improve early detection and predict whose cancer will recur. Only 7 percent of patients with pancreatic cancer are diagnosed at an early stage, which is why the cancer is so deadly. Another study is looking at novel drugs for pancreatic cancer treatment.

Long-Term Survivors Give Hope

Right now, pancreatic cancer is too often lethal. But Washington University physicians are contributing to a brighter future with new treatment regimens and surgical innovations. “Historically, the diagnosis of pancreatic cancer was tantamount to a death sentence,” Linehan says. “But through aggressive treatments and cutting-edge research, we now have several long-term survivors who are a source of hope and inspiration.”

That includes long-term survivors like Luze. “The Whipple procedure is the granddad of all abdominal surgeries, a very massive operation, and you want to go to a place where they have done a lot of them and know how to treat patients afterward,” he says. “You want the very best doctors, giving the best medical treatment.

Article from Innovate (Summer Edition of 2008)

By: Candace O’Connor

Make A Donation

Your donation funds our research, support group, symposium series and other valuable projects in our efforts to end pancreatic cancer and to support those touched by the disease.

6060 Poplar Avenue, Suite 140
Memphis, TN 38119
901-606-5330

© 2017 Herb Kosten Foundation
Web Site design & hosting by: NovaGiant

Facebook

Kosten Foundation
Kosten Foundation10 hours ago
Co-winner of the MVP Award in the 1978 Super Bowl and Dallas Cowboy Harvey Martin died of Pancreatic Cancer in 2001. #FacingPancreaticCancer
Kosten Foundation
Kosten Foundation added 9 new photos.11 hours ago
THANK YOU to our supporters, friends, family, volunteers and the entire Memphis community for another successful Kosten Foundation Purple Day! Pancreatic Cancer Awareness Month isn't over- you can still join in on the purple fun! #PurpleForKosten #WPCD #WageHope
Kosten Foundation
Kosten Foundation16 hours ago
We are honored by the City of Germantown, Tennessee Government support in bringing awareness to Pancreatic Cancer. Thank you Mayor Palazzolo for proclaiming November as "Kosten Foundation Purple Month for Pancreatic Cancer Awareness"! #PurpleForKosten #WPCD #KostenFDN www.kostenfoundation.com
Kosten Foundation
Kosten Foundation17 hours ago
Today we are lighting up #PurpleForKosten! Check out the Hernando de Soto Bridge, Big River Crossing, Liberty Bowl Memorial Stadium, Children's Museum of Memphis, Memphis Botanic Garden, and Tennessee Governor and State Capitol Buildings as they light up for #WPCD day.
Kosten Foundation
Kosten Foundation18 hours ago
Shelby County Schools - SCS Grahamwood Elementary is wearing purple today to show their support for #WPCD and #PurpleForKosten! This shot is from Guidance Counselor Mrs. Henderson and her crew! Thank you!

Sign up for Amazon SmileKroger Community Rewards, and SuperLo Foods Community Rewards and support the Kosten Foundation when you shop.